Erowid
 
 
Plants - Drugs Mind - Spirit Freedom - Law Arts - Culture Library  
References Database

References Search
All References with Titles containing 'ricaurte' OR with Authors including 'ricaurte' OR with Abstract including 'ricaurte' OR with Keywords including 'ricaurte'


Author Title JournalName Year   D
Click on Column Headers to Re-Sort The Current List
Ricaurte G, Bryan G, Stra... Hallucinogenic amphetamine selectively destroys brain serotonin nerve ... Science 1985
Ricaurte GA, Finnegan KF,... 3,4-Methylenedioxyethylamphetamine (MDE), a novel analogue of MDMA, pr... Eur J Pharmacol 1987
Wang SS, Ricaurte GA, Per... [3H]3,4-methylenedioxymethamphetamine (MDMA) interactions with brain m... Eur J Pharmacol 1987
Finnegan KT, Ricaurte GA,... Orally administered MDMA causes a long-term depletion of serotonin in ... Brain Res 1988
Ricaurte GA, DeLanney LE,... Toxic effects of MDMA on central serotonergic neurons in the primate: ... Brain Res 1988
Ricaurte GA, DeLanney LE,... 5-Hydroxyindoleacetic acid in cerebrospinal fluid reflects serotonergi... Brain Res 1988
Ricaurte GA, Forno LS, Wi... (+/-)3,4-Methylenedioxymethamphetamine selectively damages central ser... JAMA 1988
Price LH, Ricaurte GA, Kr... Neuroendocrine and mood responses to intravenous L-tryptophan in 3,4-m... Arch Gen Psychiatry 1989
Price LH, Ricaurte GA, Kr... Responses to I.V. L-tryptophan in MDMA Users NIDA Res Monogr 1989
Ricaurte GA Studies of MDMA-induced neurotoxicity in nonhuman primates: a basis fo... NIDA Res Monogr 1989
Wilson MA, Ricaurte GA, M... Distinct morphologic classes of serotonergic axons in primates exhibit... Neuroscience 1989
Ricaurte GA, Finnegan KT,... Aminergic metabolites in cerebrospinal fluid of humans previously expo... Ann N Y Acad Sci 1990
Scheffel U, Ricaurte GA Paroxetine as an in vivo indicator of 3,4-methylenedioxymethamphetamin... Brain Res 1990
Dornan WA, Katz JL, Ricau... The effects of repeated administration of MDMA on the expression of se... Pharmacol Biochem Be... 1991
McCann UD, Ricaurte GA Lasting neuropsychiatric sequelae of (+-)methylenedioxymethamphetamine... J Clin Psychopharmac... 1991
McCann UD, Ricaurte GA Major metabolites of (+/-)3,4-methylenedioxyamphetamine (MDA) do not m... Brain Res 1991
Krystal JH, Price LH, Ops... Chronic 3,4-methylenedioxymethamphetamine (MDMA) use: effects on mood ... Am J Drug Alcohol Ab... 1992
McCann UD, Ricaurte GA MDMA ('ecstasy') and panic disorder: induction by a single dose Biol Psychiatry 1992
Ricaurte GA, Martello AL,... Lasting effects of (+-)-3,4-methylenedioxymethamphetamine (MDMA) on ce... J Pharmacol Exp Ther 1992
Ricaurte GA, McCann UD Neurotoxic amphetamine analogues: effects in monkeys and implications ... Ann N Y Acad Sci 1992
Scheffel U, Lever JR, Sta... Repeated administration of MDMA causes transient down-regulation of se... Neuropharmacology 1992
Steele TD, Katz JL, Ricau... Evaluation of the neurotoxicity of N-methyl-1-(4-methoxyphenyl)-2-amin... Brain Res 1992
Zhao ZY, Castagnoli N Jr,... Synthesis and neurotoxicological evaluation of putative metabolites of... Chem Res Toxicol 1992
Allen RP, McCann UD, Rica... Persistent effects of (+/- )3,4-methylenedioxymethamphetamine (MDMA, '... Sleep 1993
McCann UD, Ricaurte GA Reinforcing subjective effects of (+/-) 3,4-methylenedioxymethamphetam... J Clin Psychopharmac... 1993
McCann UD, Ricaurte GA Strategies for detecting subclinical monoamine depletions in humans NIDA Res Monogr 1993
Miller DB, O'Callaghan JP The interactions of MK-801 with the amphetamine analogues D-methamphet... Ann N Y Acad Sci 1993
Ricaurte GA, Markowska AL... 3,4-Methylenedioxymethamphetamine, serotonin and memory [published err... J Pharmacol Exp Ther 1993
Scanzello CR, Hatzidimitr... Serotonergic recovery after (+/-)3,4-(methylenedioxy) methamphetamine ... J Pharmacol Exp Ther 1993
McCann UD, Ridenour A, Sh... Serotonin neurotoxicity after (+/-)3,4-methylenedioxymethamphetamine (... Neuropsychopharmacol... 1994
Scheffel U, Dannals RF, S... Development of PET/SPECT ligands for the serotonin transporter NIDA Res Monogr 1994
Schifano F, Magni G MDMA ('ecstasy') abuse: psychopathological features and craving for ch... Biol Psychiatry 1994
Steele TD, McCann UD, Ric... 3,4-Methylenedioxymethamphetamine (MDMA, 'Ecstasy'): pharmacology and ... Addiction 1994
Fischer C, Hatzidimitriou... Reorganization of ascending 5-HT axon projections in animals previousl... J Neurosci 1995
McCann UD, Ricaurte GA On the neurotoxicity of MDMA and related amphetamine derivatives [lett... J Clin Psychopharmac... 1995
McCann UD, Slate SO, Rica... Adverse reactions with 3,4-methylenedioxymethamphetamine (MDMA; 'Ecsta... Drug Safety 1996
Saunders N Ecstasy and neurodegeneration. No Evidence of Neurotoxicity Exists BMJ 1996
Bolla KI, McCann UD, Rica... Memory impairment in abstinent MDMA ('Ecstasy') users Neurology 1998
Scheffel U, Szabo Z, Math... In vivo detection of short- and long-term MDMA neurotoxicity--a positr... Synapse 1998
McCann UD, Szabo Z, Schef... Positron emission tomographic evidence of toxic effect of MDMA ('Ecsta... Lancet 1998
McCann UD, Szabo Z, Schef... Toxic effect of MDMA on brain serotonin neurons Lancet 1999
McCann UD, Szabao Z, Sche... Positron emission tomography findings in heavy users of MDMA Lancet 1999
Hatzidimitriou G, McCann ... Altered serotonin innervation patterns in the forebrain of monkeys tre... J Neurosci 1999
McCann UD, Mertl M, Eligu... Cognitive performance in (+/-) 3,4-methylenedioxymethamphetamine (MDMA... Psychopharmacology (... 1999
McCann UD, Eligulashvili ... Altered neuroendocrine and behavioral responses to m-chlorophenylpiper... Psychopharmacology (... 1999
McCann UD, Eligulashvili ... (+/-)3,4-Methylenedioxymethamphetamine (`Ecstasy')-Induced Serotonin N... Neuropsychobiology 2000
Ricaurte GA, Yuan J, McCa... (+/-)3,4-Methylenedioxymethamphetamine (`Ecstasy')-Induced Serotonin N... Neuropsychobiology 2000
Ricaurte GA, McCann UD, S... Toxicodynamics and long-term toxicity of the recreational drug, 3, 4-m... Toxicol Lett 2000
McCann UD, Ricaurte GA Caveat Emptor: Editors Beware Neuropsychopharmacol... 2001
Aghajanian GK, Liebermann... Caveat Emptor: Editors Beware Neuropsychopharmacol... 2001
Vollenweider FX, Jones RT... Caveat Emptor: Editors Beware (reply) Neuropsychopharmacol... 2001
Callahan BT, Cord BJ, Ric... Long-Term Impairment of Anterograde Axonal Transport Along Fiber Proje... Synapse 2001
McCann UD, Ricaurte GA, M... 'Ecstasy' and serotonin neurotoxicity: New findings raise more questio... Archives of General ... 2001
Ricaurte GA, McCann UD Assessing long-term effects of MDMA (Ecstasy) Lancet 2001
Winsauer PJ, McCann UD, Y... Effects of fenfluramine, m-CPP and triazolam on repeated-acquisition i... Psychopharmacology (... 2002
Hatzidimitriou G, Tsai EH... Altered prolactin response to M-chlorophenylpiperazine in monkeys prev... Synapse 2002
Yuan J, Cord BJ, McCann U... Effect of depleting vesicular and cytoplasmic dopamine on methylenedio... J Neurochem 2002
Szabo Z, McCann UD, Wilso... Comparison of (+)-(11)C-McN5652 and (11)C-DASB as Serotonin Transporte... J Nucl Med 2002
Bobes J, Saiz PA, Gonzale... Use of MDMA and Other Illicit Drugs by Young Adult Males in Northern S... Eur Addict Res 2002
Ricaurte GA, Yuan J, Hatz... Severe Dopaminergic Neurotoxicity in Primates After a Common Recreatio... Science 2002
Holden C Drug find could give ravers the jitters Science 2002
Reneman L, Booij J, Habra... Validity of [123I]beta-CIT SPECT in detecting MDMA-induced serotonergi... Synapse 2002
Yuan J, Cord BJ, McCann U... Effect of glucoprivation on serotonin neurotoxicity induced by substit... J Pharmacol Exp Ther 2002
Boot BP, Mechan AO, McCan... MDMA- and p-chlorophenylalanine-induced reduction in 5-HT concentratio... Eur J Pharmacol 2002
Butcher J MDMA research leaves ravers far from ecstatic Lancet Neurol 2002
Taffe MA, Davis SA, Yuan ... Cognitive performance of MDMA-treated rhesus monkeys: sensitivity to s... Neuropsychopharmacol... 2002
Ricaurte GA, Yuan J, Hatz... Retraction Science 2003
Bartlett T Ecstasy agonistes: a retracted study on a controversial substance rais... Chron High Educ 2004
Fantegrossi WE, Woolverto... Behavioral and Neurochemical Consequences of Long-Term Intravenous Sel... Neuropsychopharmacol... 2004
Mechan A, Yuan J, Hatzidi... Pharmacokinetic Profile of Single and Repeated Oral Doses of MDMA in S... Neuropsychopharmacol... 2005
McCann UD, Szabo Z, Secki... Quantitative PET Studies of the Serotonin Transporter in MDMA Users an... Neuropsychopharmacol... 2005
McCann UD, Szabo Z, Vrane... Positron emission tomographic studies of brain dopamine and serotonin ... Psychopharmacology (... 2008
Mueller MA, Yuan J, Neudo... Further Studies on the Role of Metabolites in MDMA-induced Serotonergi... Drug Metab Dispos 2009
Mueller M, Goodwin AK, At... Metabolism and Disposition of 3,4-Methylenedioxymethamphetamine (MDMA,... J Pharmacol Exp Ther 2011